SCHEMBL13376242

SCHEMBL13376242

Cc1cccc(-c2ccc(N=O)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.45
▸ HSD17B1 P14061 1/20 0.45
▸ HSD17B2 P37059 1/20 0.45
▸ ENPP3 O14638 1/20 0.45
▸ FYN P06241 1/20 0.42
▸ CLK4 Q9HAZ1 1/20 0.42
▸ DYRK1B Q9Y463 1/20 0.42
▸ ACHE P22303 1/20 0.42
▸ AKR1C2 P52895 1/20 0.41
▸ AKR1C1 Q04828 1/20 0.41
▸ MAPT P10636 2/20 0.41
▸ PARP10 Q53GL7 1/20 0.41
▸ PARP11 Q9NR21 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ CTDSP1 Q9GZU7 1/20 0.40
▸ PTPN5 P54829 1/20 0.40
▸ FNTA P49354 1/20 0.40
▸ FNTB P49356 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ CASP3 P42574 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6561397 0.82 ACHE (0.61) PGRHSD17B1HSD17B2ENPP3FYN
SCHEMBL18797759 0.80 ACHE (0.65) PGRHSD17B1HSD17B2ENPP3ACHE
SCHEMBL2405824 0.79 CYP3A4 (0.44) PGRHSD17B1HSD17B2ENPP3FYN
SCHEMBL13547631 0.78 ALDH1A1 (0.46) ACHEAKR1C2AKR1C1MAPTNPC1
SCHEMBL29057032 0.78 ACHE (0.55) PGRHSD17B1HSD17B2ENPP3FYN
SCHEMBL23003863 0.78 ACHE (0.55) PGRHSD17B1HSD17B2ENPP3FYN
SCHEMBL29929976 0.78 ACHE (0.55) PGRHSD17B1HSD17B2ENPP3FYN
SCHEMBL5545442 0.78 ACHE (0.55) PGRHSD17B1HSD17B2ENPP3FYN
SCHEMBL20689786 0.78 TSHR (0.55) PGRHSD17B1HSD17B2ENPP3ACHE
SCHEMBL30493472 0.78 ACHE (0.55) PGRHSD17B1HSD17B2ENPP3FYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2177518-A1 Organic compounds Novartis AG (CH) 2010-04-21 — — EP disclosed
Send feedback